A species of human alpha interferon that lacks the ability to boost human natural killer activity - PubMed (original) (raw)
A species of human alpha interferon that lacks the ability to boost human natural killer activity
J R Ortaldo et al. Proc Natl Acad Sci U S A. 1984 Aug.
Abstract
Most species of recombinant leukocyte interferons (IFN-alpha A, -alpha B, -alpha C, -alpha D, -alpha F, -alpha I, and -alpha K) were capable of boosting human natural killer (NK) activity after a 2-hr treatment of cells at a concentration of 1-80 units/ml. In contrast, recombinant human IFN-alpha J was found to be incapable of augmenting NK activity after exposure of cells for 2 hr to concentrations as high as 10,000 units/ml. This inability of IFN-alpha J to boost NK activity was not complete because, after exposure of cells to a high concentration of IFN-alpha J (10,000 units/ml) for 18 hr, boosting of cytolysis was observed. IFN-alpha J appeared to interact with receptors for IFN on NK cells since it was found to interfere with the boosting of NK activity by other species of IFN-alpha. In contrast to its deficient ability to augment NK activity, IFN-alpha J has potent antiviral and antiproliferative activities. Such extensive dissociation of these biological activities has not been observed previously with any other natural or recombinant IFN species. Thus, this IFN species may be useful for evaluating the relative importance of various biological activities on the therapeutic effects of IFN, for understanding structure-function relationships, and for determining the biochemical pathways related to the various biological effects of IFN.
Similar articles
- Regulation of natural killer cytotoxicity by recombinant alpha interferons. Augmentation by IFN-alpha 7, an interferon similar to IFN-alpha J.
Platsoucas CD, Fox FE, Oleszak E, Fong K, Nanno M, Ioannides CG, Trotta PP. Platsoucas CD, et al. Anticancer Res. 1989 Jul-Aug;9(4):849-58. Anticancer Res. 1989. PMID: 2817813 - Binding of human alpha-interferons to natural killer cells.
Langer JA, Ortaldo JR, Pestka S. Langer JA, et al. J Interferon Res. 1986 Apr;6(2):97-105. doi: 10.1089/jir.1986.6.97. J Interferon Res. 1986. PMID: 2941494 - Alpha-interferon structure and natural killer cell stimulatory activity.
Li BL, Zhao XX, Liu XY, Kim HS, Raska K Jr, Ortaldo JR, Schwartz B, Pestka S. Li BL, et al. Cancer Res. 1990 Sep 1;50(17):5328-32. Cancer Res. 1990. PMID: 2201435 - Type I interferon regulation of natural killer cell function in primary and secondary infections.
Stackaruk ML, Lee AJ, Ashkar AA. Stackaruk ML, et al. Expert Rev Vaccines. 2013 Aug;12(8):875-84. doi: 10.1586/14760584.2013.814871. Expert Rev Vaccines. 2013. PMID: 23984959 Review. - Interferon-zeta/limitin: novel type I interferon that displays a narrow range of biological activity.
Oritani K, Tomiyama Y. Oritani K, et al. Int J Hematol. 2004 Nov;80(4):325-31. doi: 10.1532/ijh97.04087. Int J Hematol. 2004. PMID: 15615256 Review.
Cited by
- Interferon-α and its effects on cancer cell apoptosis.
Shi W, Yao X, Fu Y, Wang Y. Shi W, et al. Oncol Lett. 2022 May 30;24(1):235. doi: 10.3892/ol.2022.13355. eCollection 2022 Jul. Oncol Lett. 2022. PMID: 35720476 Free PMC article. Review. - A panel of synthetic antibodies that selectively recognize and antagonize members of the interferon alpha family.
Miersch S, Kuruganti S, Walter MR, Sidhu SS. Miersch S, et al. Protein Eng Des Sel. 2017 Sep 1;30(9):697-704. doi: 10.1093/protein/gzx048. Protein Eng Des Sel. 2017. PMID: 28981904 Free PMC article. - Interferon-alpha subtype 11 activates NK cells and enables control of retroviral infection.
Gibbert K, Joedicke JJ, Meryk A, Trilling M, Francois S, Duppach J, Kraft A, Lang KS, Dittmer U. Gibbert K, et al. PLoS Pathog. 2012;8(8):e1002868. doi: 10.1371/journal.ppat.1002868. Epub 2012 Aug 9. PLoS Pathog. 2012. PMID: 22912583 Free PMC article. - Interferon-β inhibits toll-like receptor 9 processing in multiple sclerosis.
Balashov KE, Aung LL, Vaknin-Dembinsky A, Dhib-Jalbut S, Weiner HL. Balashov KE, et al. Ann Neurol. 2010 Dec;68(6):899-906. doi: 10.1002/ana.22136. Ann Neurol. 2010. PMID: 21061396 Free PMC article. - Dissecting interferon-induced transcriptional programs in human peripheral blood cells.
Waddell SJ, Popper SJ, Rubins KH, Griffiths MJ, Brown PO, Levin M, Relman DA. Waddell SJ, et al. PLoS One. 2010 Mar 22;5(3):e9753. doi: 10.1371/journal.pone.0009753. PLoS One. 2010. PMID: 20339534 Free PMC article.
References
- Nature. 1979 Jan 18;277(5693):221-3 - PubMed
- J Interferon Res. 1983;3(2):231-9 - PubMed
- J Biol Chem. 1981 Mar 10;256(5):2113-4 - PubMed
- J Exp Med. 1981 Mar 1;153(3):569-82 - PubMed
- J Biol Chem. 1981 Sep 25;256(18):9750-4 - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources